Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Publication Date : //
Drug nanocrystals (NCs) with fascinating physicochemical properties have attracted great attention in drug delivery. High drug-loading efficiency, great structural stability, steady dissolution, and long circulation time are a few examples of these properties, which makes drug NCs an excellent formulation for efficient cancer therapy. In the last two decades, there are a lot of hydrophobic or lipophilic drugs, such as paclitaxel (PTX), camptothecin (CPT), thymectacin, busulfan, cyclosporin A, 2-devinyl-2-(1-hexyloxyethyl) pyropheophorbide (HPPH), and so on, which have been formulated into drug NCs for cancer therapy. In this review, we summarized the recent advances in drug NCs-based cancer treatment. So far, there are main three methods to synthesize drug NCs, including top-down, bottom-up, and combination methods. The characterization methods of drug NCs were also elaborated. Furthermore, the applications and mechanisms of drug NCs were introduced by their administration routes. At the end, we gave a brief conclusion and discussed the future perspectives of drug NCs in cancer therapy. This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.
Authors : Miao Xiaoqing , Yang Wuwei , Feng Tao , Lin Jing , Huang Peng ,
Related products :
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
email@example.com | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1108: Hypothetical Network for Drug Addiction
WP1246: Hypothetical Network for Drug Addiction
WP1281: Hypothetical Network for Drug Addiction
WP1333: Hypothetical Network for Drug Addiction
WP1589: Folate-Alcohol and Cancer Pathway
WP1968: genetic alternations of lung cancer
WP1971: Integrated Cancer pathway
WP1984: Integrated Breast Cancer Pathway
WP2107: pathways in human cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2263: Prostate Cancer
WP2289: Drug Induction of Bile Acid Pathway
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2335: sGC Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2367: Private Pancreatic Cancer
WP2377: Integrated Pancreatic Cancer Pathway
WP2411: Cancer prevention Q
WP2429: Cancer prevention Q
WP666: Hypothetical Network for Drug Addiction
WP764: Hypothetical Network for Drug Addiction
WP873: Hypothetical Network for Drug Addiction
WP991: Hypothetical Network for Drug Addiction
Related Genes :
 Nano strategies for berberine delivery, a natural alkaloid of Berberis.
 Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
 DNA decorated CuS nanoparticles as NIR light responsive drug carriers for tumor chemo-phototherapy.
 Targeting Sugar Uptake and Metabolism for Cancer Identification and Therapy: An Overview.
 Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy.
 Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
 Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies.
 Hydrophobic interaction mediated coating of Pluronics on mesoporous silica nanoparticle with stimuli responsiveness for cancer therapy.
 Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
 Biological Stimulus-Driven Assembly/Disassembly of Functional Nanoparticles for Targeted Delivery, Controlled Activation, and Bioelimination.
Enter catalog number :